The following clinical trials are associated with All diseases and conditions.
-
expand
Drug utilization and safety events among children using esomeprazole, other proton pump inhibitors or H2-receptor antagonists
- Study Id
- D9612N00016
- Disease
- gastroesophageal reflux disease
- Drug Name
- Nexium
- Study Name
- D9612N00016
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Part, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Plasma and Cerebrospinal Fluid in Healthy Male and Non-Fertile Female Elderly Volunteers and in Mild-to-Moderate Alzheimer Disease Patients.
- Study Id
- D5010C00002
- Disease
- Alzheimer's Disease
- Drug Name
- AstraZeneca Neuroscience Development Drugs
- Study Name
- D5010C00002
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Observational retrospective Study to Describe the Management of Advanced or Metastatic EGFR Mutated Non-small Cell Lung Cancer Patients in Spain.
- Study Id
- NIS-OES-XXX-2012/1
- Disease
- non-small cell lung cancer
- Drug Name
- non drug study (oncology)
- Study Name
- NIS-OES-XXX-2012/1
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy, Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections In Hospitalized Adults
- Study Id
- D4280C00018
- Disease
- infection
- Drug Name
- CAZ-104
- Study Name
- RECLAIM3
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A diagnostic study to determine the prevalence of EGFR mutations in Asian and Russian patients with advanced NSCLC of Adenocarcinoma and Non-adenocarcinoma histologies
- Study Id
- D7913C00074
- Disease
- non-small cell lung cancer
- Drug Name
- non drug study (oncology)
- Study Name
- D7913C00074
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Tolerability,Pharmacokinetics&Preliminary Antitumour Activity of Ascending Doses of AZD9291 in Patients With Advanced Non Small Cell LungCancer Who Have Progressed Following Prior Therapy With an Epidermal Growth FactorReceptorTyrosineKinaseInhibatoragent
- Study Id
- D5160C00001
- Disease
- non-small cell lung cancer
- Study Name
- D5160C00001
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer (ACT-FASTER:)
- Study Id
- NIS-ODE-FAS-2009/1
- Disease
- advanced breast cancer
- Drug Name
- Faslodex
- Study Name
- NIS-ODE-FAS-2009/1
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
D1691C00007
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
D0490C00005
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A multi-center, randomised, double-blind, parallel-group phase III study to assess high dose esomeprazole Na i.v. treatment (bolus infusion of 80 mg followed by a continuous infusion of 8 mg per hour administered for 72 hours) for prevention of rebleeding.
- Study Id
- D961DC00007
- Disease
- gastrointestinal bleeding, peptic ulcer
- Drug Name
- AstraZeneca Gastrointestinal Brands
- Study Name
- D961DC00007
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
